Regarding Methotrexate administration, which statement is incorrect?

Prepare for the Internal Medicine II Test with engaging flashcards and multiple-choice questions. Each question is detailed with hints and explanations. Gear up your knowledge for success!

Multiple Choice

Regarding Methotrexate administration, which statement is incorrect?

Explanation:
The key idea is how methotrexate is used and what its usual toxicities are. Methotrexate is given weekly rather than daily to limit cumulative toxicity, and its well-known adverse effects include bone marrow suppression and liver toxicity (which can progress to liver fibrosis with long-term use). While the drug is cleared by the kidneys and high doses can cause nephrotoxicity if hydration is inadequate or renal function is poor, kidney failure is not a typical, predictable adverse effect of standard methotrexate therapy. In other words, kidney failure is not the expected adverse effect you would rely on as a common risk, whereas weekly dosing and the hematologic and hepatic toxicities are characteristic.

The key idea is how methotrexate is used and what its usual toxicities are. Methotrexate is given weekly rather than daily to limit cumulative toxicity, and its well-known adverse effects include bone marrow suppression and liver toxicity (which can progress to liver fibrosis with long-term use). While the drug is cleared by the kidneys and high doses can cause nephrotoxicity if hydration is inadequate or renal function is poor, kidney failure is not a typical, predictable adverse effect of standard methotrexate therapy. In other words, kidney failure is not the expected adverse effect you would rely on as a common risk, whereas weekly dosing and the hematologic and hepatic toxicities are characteristic.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy